Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Prof Vincenzo Cerundolo elected Fellow of the Royal Society

Many congratulations to our close colleague, Prof Vincenzo Cerundolo, Director of the MRC Human Immunology Unit for this prestigious honour recognising his pioneering work on T cell immunology.

Read the full article

Similar stories

Oxford Bundibugyo ebolavirus vaccine candidate receives CEPI backing

The Coalition for Epidemic Preparedness Innovations (CEPI) has announced today that it will urgently accelerate the development of three investigational vaccines targeting the Bundibugyo ebolavirus that has caused a rapidly spreading epidemic in the Democratic Republic of the Congo (DRC) and neighbouring Uganda, including one being developed by the Oxford Vaccine Group at the University of Oxford.

UK and France launch landmark biomedical and AI health alliance to accelerate research into major diseases

Academy of Medical Sciences elects three researchers from the Nuffield Department of Medicine as new Fellows

New study improves early detection of life threatening infection in children across South and South East Asia

New rabies vaccine could provide protection for adults and children with a single dose

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment